Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
CRSP reports encouraging fourth-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is ...
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback